
Stock Movers Danaher Agrees to Buy Masimo; Norwegian Cruise Shares Rise; Warner Bros. Reopens Deal Talks
Feb 17, 2026
A quick rundown of a $9.9 billion acquisition in medical tech and the big cash-per-share offer behind it. A spike in cruise-stock trading after an activist investor builds a large stake. Renewed bidding drama in Hollywood as one studio reopens sale talks, potentially triggering another bidding push.
AI Snips
Chapters
Transcript
Episode notes
Danaher's Premium Buyout Of Masimo
- Danaher's all-cash $180-per-share offer values Masimo at about $10 billion and pays a roughly 40% premium to recent close.
- The deal highlights consolidation in patient-monitoring tech as aging populations and chronic disease drive steady market growth.
Massimo's Patent Win Strengthens Its Value
- Massimo recently won a $634 million patent verdict against Apple over heart-rate alert technology.
- That legal win underscores Massimo's IP value and may have strengthened its negotiating position with Danaher.
Elliott Builds Stake In Norwegian Cruise
- Elliott Investment Management built a stake north of 10% in Norwegian Cruise, pushing the stock up over 6% premarket.
- Activist involvement signals potential board changes and operational focus to close performance gaps with rivals.
